PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsTuberculosis
MeSH D014376 - tuberculosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D009164:Mycobacterium infections
$
Success rate
D014376: 
Tuberculosis
D014375:Tuberculoma
0 Companies
0 Drugs
Success rate
D014379:Avian tuberculosis
0 Companies
0 Drugs
Success rate
D014380:Bovine tuberculosis
0 Companies
0 Drugs
Success rate
D014391:Miliary tuberculosis
0 Companies
0 Drugs
Success rate
D014397:Pulmonary tuberculosis
D018088:Multidrug-resistant tuberculosis
$
Success rate
D055985:Latent tuberculosis
$
Success rate
D000092225:Extrapulmonary tuberculosis
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaIsoniazid Isoniazid  1982-01-01   
MylanCapreomycin Capreomycin  2017-11-27   
Rifampin Rifampin  2008-05-22   
PerrigoIsoniazid Isoniazid  1982-01-01   
RocheIsoniazid Rimifon  1982-01-01   
Lupin ResearchEthambutol Ethambutol  2009-06-17   
Rifampin Rifampin  2013-08-21   
SandozIsoniazid Isoniazid  2005-07-05   
Isoniazid Nydrazid  1982-01-01   
NovartisIsoniazid Inh  1982-01-01   
SanofiRifampin Rifadin  1982-01-01   
Isoniazid, Rifampin Rifamate  1982-01-01   
Isoniazid, Rifampin, Pyrazinamide Rifater  1994-05-31   
WyethEthionamide Trecator  1982-01-01   
Eli LillyIsoniazid Isoniazid  1982-01-01   
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
69%
33/48
Phase 2
61%
46/75
Phase 3
48%
32/67
Approved: 11Overall Success rate: 20%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use